• About Us
    • List of Regulators
    • News Websites
  • What We Do
    • Downloads
  • Mission
  • Vision
  • Contact Us
  • Terms of use
  • Privacy Policy
  • Disclaimer
Investadvocate
  • Home
  • Business News
    • Capital Market
    • Money Market
    • Fraud & Scandals
    • Results & Dividends
  • Updates
  • Investors Bite
  • World News
  • Trending
  • Over-the-Counter Beat
  • Q & A Session

All Posts in "Q & A Session"

IMF – FAQ: The IMF’s Response to COVID-19

IMF – FAQ: The IMF’s Response to COVID-19

April 10, 2020/IMF As IMF Managing Director Kristalina Georgieva said during her speech going into…
by InvestAdvocate — April 10, 2020 in Q & A Session 0
African Risk Capacity The Outbreaks & Epidemics product in the context of Covid-19

African Risk Capacity The Outbreaks & Epidemics product in the context of Covid-19

March 25/ARC Introduction: African Risk Capacity’s Outbreaks & Epidemics Programme:Coronavirus This paper seeks to advise…
by InvestAdvocate — March 25, 2020 in Q & A Session 0
Policy Action for a Healthy Global Economy

Policy Action for a Healthy Global Economy

March 16, 2020/IMFBlog This blog is part of a special series on the response to…
by InvestAdvocate — March 16, 2020 in OPINION/EDITORIAL 0

Posts pagination

Previous 1 … 18 19 20 … 34 Next
DAILY TOP GAINERS
COYOPENING PRICECLOSING PRICE% CHG
CADBURY57.0062.70+10.00%
TRANSEX  2.80  3.08+10.00%
UNILEVER125.00137.50+10.00%
THOMAS    3.72    4.09+9.95%
UPDCREIT   11.70   12.80+9.40%
DAILY TOP LOSERS
COYOPENING PRICECLOSING PRICE% CHG
NESTLE3,125.002,812.50-10.00%
BUAFOOD  9.39.00   845.10-10.00%
MECURE      76.95     69.30-9.94%
INTNEGINS         4.88         4.40-9.84%
UACN    199.95    184.45-7.75%

Source: NGX as at July 22, 2026

APO NEWSROOM

Follow Investadvocate on Twitter

Tweets by @investadvocate

Regulators Links

 

NGX

SEC

CBN

EFCC

CSCS

NDIC

MORE

 

TV Stations

 

CNN

AlJazeera

TVC News

AIT

Channels TV

BBC

CNBC

News Websites

 

Yahoo! News 

Premier League

The Will 

Proshare

Huhuonline

Financial Times 

More

 

opan

 

 

© 2026 Investadvocate ·